Home workouts may ease Chemotherapy's toll on breast cancer patients

NCT ID NCT07716306

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests whether a 24-week, remotely supervised exercise program combining aerobic intervals and resistance training can improve physical health and quality of life in women with breast cancer undergoing chemotherapy. Participants, aged 30-65 with stage II-III breast cancer, will be randomly assigned to either the exercise group or a control group. The program uses a smartwatch, heart rate monitor, and resistance bands with sensors, with sessions three times per week. Researchers will measure changes in cardiorespiratory fitness, muscle strength, cognitive function, and side effects from chemotherapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
remotely supervised combined aerobic high-intensity interval and resistance exercise training
What this could lead to
If effective, this approach could offer a convenient, home-based way to reduce chemotherapy side effects and improve quality of life for breast cancer patients.
What could go wrong
This is a small, early-stage trial with 60 participants, so results may not apply to all patients. Adherence to remote exercise may vary, and the intervention may not significantly reduce side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Riga Stradins University

    Riga, LV1007, Latvia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.